サンプル依頼リスト カート
表紙：イムノアッセイの世界市場 - 動向、技術、成長の機会（2025年）
市場調査レポート
商品コード
1747992

イムノアッセイの世界市場 - 動向、技術、成長の機会（2025年）

Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025

出版日
ページ情報
英文 460 Pages
納期
即日から翌営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.36円
イムノアッセイの世界市場 - 動向、技術、成長の機会（2025年）
出版日: 2025年06月13日
発行: Kalorama Information
ページ情報: 英文 460 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

最新レポート「イムノアッセイの世界市場 - 動向、技術、成長の機会（2025年）」は、体外診断（IVD）業界の最も重要なセグメントの1つであるイムノアッセイを詳細に分析し、2024年から2029年までの市場推計・予測を掲載しています。イムノアッセイ-抗体と抗原の相互作用によって標的分析物を検出する診断テスト-は、臨床検査室やポイントオブケア（POC）環境における基礎的なツールであり、タンパク質、ホルモン、薬物、感染性物質の検出を可能にします。

世界のイムノアッセイ市場は、自動化、小型化、多重化、バイオマーカー探索の進歩によって拡大を続けています。イムノアッセイは成熟した技術であるにもかかわらず、中央検査室から自己検査アプリケーションまで、現代のヘルスケアニーズに対応するために急速に進化しています。

市場セグメンテーション

セッティング別

  • 中央ラボベースのイムノアッセイ法：
    • コアラボで診断、モニタリング、スクリーニングに使用されます。
    • 市場売上：主な寄与：感染症、心臓マーカー、腫瘍マーカーなど
    • 主要セグメント
      • 感染症マーカー
      • 心臓マーカー
      • 代謝疾患とホルモン
      • 腫瘍マーカー
      • 自己免疫・アレルギー検査
  • ポイントオブケア（POC）イムノアッセイ：
    • 病院、診療所、小売店、自己検査におけるラテラルフローやその他の迅速検査を含みます。
    • 使いやすさとアクセスの分散化により急成長
    • 主な対象セグメント
      • 感染症
      • ホルモン／不妊
      • 心臓マーカー
      • 腫瘍学およびFOBT
      • 毒性学

疾患カテゴリー別内訳

  • 感染症：HIV、肝炎、MRSA、性病、COVID-19、TORCHなどの検査が含まれます。
  • 心臓マーカー：心不全検査と急性期医療検査で力強く成長しています。
  • ホルモンと不妊症：ラボとPOCの両方で高い利用率です。
  • 腫瘍/腫瘍マーカー：PSA、CEA、CA-125、AFPが中心で、ラボベースが優勢です。
  • 毒物学と薬物モニタリング：疼痛管理、救急医療、薬物乱用プログラムで使用されます。
  • 自己免疫とアレルギー：全身性疾患に対する新たなターゲットと拡張パネル。
  • 遺伝子検査：出生前スクリーニングやイムノアッセイプラットフォーム別遺伝子発現プロファイリングを含みます。
  • その他の新領域アルツハイマー病、消化器疾患、移植医療、女性の健康（子癇前症など）。

地域動向分析

  • 新興国市場：
    • 北米と西欧は、高度なヘルスケア・インフラと先進的な診断法の導入により優位を占めています。
    • 先進アジア太平洋も重要な役割を果たしています。
  • 新興市場：
    • ラテンアメリカ、東欧、東南アジア、アフリカでは、集中型診断が限られているため、イムノアッセイがアクセス拡大の鍵となります。
    • リソースの限られた環境では、ラテラルフローと自己検査が重要なツールとなります。

調査手法と範囲

当レポートでは、2024年から2029年までを対象とした世界のイムノアッセイ市場を米国ドル建てで紹介しています。当レポートでは、ハイスループットのラボ機器から、迅速イムノクロマト法やラテラルフロー法を含む手動のポイントオブケア（POC）検査まで、幅広いイムノアッセイ技術を分析しています。

先進地域（北米、西欧、アジア太平洋地域）に主眼を置く一方、十分なサービスを受けていない地域における診断アクセスの拡大におけるPOC検査の重要性も認識しています。

市場データは小売価格や償還額ではなく、メーカーの収益を反映しています。機器のコストは検査ごとの価格設定にバンドルされることが多いため、セグメント値は一般的に検査量と一致しています。

当レポートの調査結果は、1次調査と2次調査を組み合わせたものです。二次情報源としては、公開会社および独自のデータベース、業界レポート、規制当局への届出、会社刊行物、査読付きジャーナルなどがあります。これらの情報源から、背景、競合他社の特定、戦略的洞察が得られました。

調査の検証と深化のため、Kalorama社は経営幹部、製品・マーケティングリーダー、コンサルタント、ヘルスケア専門家、政府代表者などの業界専門家とのインタビューを30回以上実施しました。これらのインタビューから、市場力学や動向に関する定性的な洞察が得られました。

企業への追加的な働きかけにより、収益、市場シェア、製品性能に関する具体的な数値が得られました。すべてのデータは、複数の情報源と照合し、可能な限り、公開情報、独自の洞察、専門家のフィードバックを用いて検証しました。

市場規模および予測は、2024年を基準年としており、2029年までの予測は、過去の動向、人口動態の変化、技術の進歩、世界の市場拡大によって裏付けられています。競合情勢分析は2024年の情勢を反映し、それ以降の動向も明らかにしています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

  • イムノアッセイの歴史と未来
  • イムノアッセイ技術は進化し続けている

第3章 テクノロジー、動向、イノベーション

  • 概要- イムノアッセイ
    • 化学発光イムノアッセイ（CLIA）
    • 酵素イムノアッセイ（ELISA）
    • 蛍光イムノアッセイ（FIA）
    • 免疫組織化学（IHC）
    • ラテラルフローイムノアッセイ（LFIA）
    • ラジオイムノアッセイ（RIA）
    • ウェスタンブロッティング
  • イムノアッセイ技術の革新と新たな動向
  • 概要- 計器プラットフォーム
    • マイクロタイタープレートを用いたイムノアッセイと自動化
    • イムノアッセイの自動化
    • プラットフォームのイノベーション：小型化、マイクロ流体、マルチプレックス化
    • ポイントオブケア（POC）と小型デバイス
    • ラボオンチップ（LOC）とバイオチップ
    • 事例：Veravas VeraBINDテクノロジー
  • 試料の種類
    • 血
    • 尿
    • 唾液

第4章 設定別市場セグメント

  • 中央研究所
  • 迅速・ポイントオブケア検査

第5章 イムノアッセイ診断市場の用途別動向

  • アレルギー
  • 自己免疫疾患
  • 心臓マーカー
  • 遺伝子検査
  • 感染症
  • ラボベースの感染症イムノアッセイ
    • 血液検査
    • 肝炎
    • ライム病
    • 迅速テストとPOCテスト
    • レトロウイルス
    • 性感染症
    • トーチ
    • COVID-19
    • その他の感染症
  • 代謝障害とその他のホルモン
    • 妊娠・生殖ホルモン
    • 甲状腺
  • 腫瘍学- 腫瘍マーカー
    • ラボベースの腫瘍イムノアッセイ
  • 毒物学
    • 乱用薬物
    • 治療薬物モニタリング
  • イムノアッセイ疾患市場におけるその他の疾患カテゴリー

第6章 イムノアッセイの市場機会と課題

  • イムノアッセイ市場- 概要
  • イムノアッセイ市場促進要因・課題
    • 促進要因
  • イムノアッセイ法の革新における新たな分野
    • 胃腸障害
    • 移植管理
    • 妊娠中毒症
    • アルツハイマー病
  • 新興国際市場
  • ラボ開発テスト
  • 人員不足
  • イムノアッセイの今後の見通し

第7章 イムノアッセイ市場分析

  • 市場概要と市場セグメント
  • 競合分析
  • 地域別イムノアッセイ市場
    • 北米
    • 欧州
    • アジア太平洋
    • その他の国

第8章 企業プロファイル

  • 1 Step Detect Associates, LLC
  • Abbott Laboratories
  • Abingdon Health, Ltd.
  • Access Bio, Inc
  • AccuBioTech Co, Ltd.
  • ACON Laboratories, Inc
  • AESKU. DIAGNOSTICS
  • Aidian Oy
  • Alfa Scientific Designs, Inc
  • American Laboratory Products Company (ALPCO)
  • Anbio Biotechnology
  • ARKRAY, Inc
  • Arlington Scientific, Inc.
  • Artron Laboratories Inc.
  • Associates of Cape Cod, Inc. (ACC)
  • Autobio Diagnostics Co., Ltd
  • Avioq, Inc
  • Awareness Technology
  • Beckman Coulter, Inc
  • Becton Dickinson (BD)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • BioCheck, Inc.
  • Biohit Oyj (Biohit Healthcare)
  • bioLytical Laboratories
  • BioMedomics, Inc.
  • Biomerica
  • bioMerieux SA
  • BioPorto Diagnostics
  • Bio-Rad Laboratories Inc.
  • Bioscience (Tianjin) Diagnostic Technology Co., Ltd.
  • Bio-Techne
  • Biotron Diagnostics, Inc.
  • Boditech Med Inc.
  • Boson Biotech Co. Ltd
  • BUHLMANN Laboratories AG
  • Certest Biotec
  • Chembio Diagnostic Systems, Inc.
  • Clarity Diagnostics, LLC
  • Confirm Biosciences
  • CTK Biotech, Inc.
  • Diagenics Group SE
  • DIALAB GmbH
  • Diametra
  • DiaSorin S.p.A.
  • DiaSource ImmunoAssays SA
  • DiaSys Diagnostic Systems GmbH (Mindray)
  • Diazyme Laboratories, Inc.
  • Dr. Fooke-Achterrath Laboratorien GmbH
  • Eiken Chemical Co Ltd.
  • EKF Diagnostics Holdings plc
  • ELITechGroup S.A.S.
  • Eurobio Scientific
  • Eurospital Spa
  • EY Laboratories
  • Fujirebio-US, Inc.
  • GenBio
  • Gold Standard Diagnostics
  • Grifols International S.A.
  • Hemosure, Inc.
  • HYCOR Biomedical, Inc.
  • Immuno-Mycologics, Inc.
  • Immunosciences Lab, Inc.
  • Immunostics, Inc
  • InBios International, Inc.
  • JAL Innovation PTE LTD
  • Jant Pharmacal Corporation
  • J Mitra & Co., Pvt. Ltd.
  • KRONUS
  • Kypha
  • Labsystems Diagnostics Oy
  • LamdaGen Corporation
  • LifeSign, LLC
  • Macherey-Nagel GmbH & Co. KG
  • Medix Biochemica
  • MedMira, Inc
  • Mercodia AB
  • Meridian BioScience, Inc
  • Monobind, Inc
  • Nano-Ditech Corporation
  • Nexus Dx Inc
  • Nova Biomedical, Corp.
  • Oasis Diagnostics Corporation
  • Operon
  • OPKO Health, Inc
  • OraSure Technologies, Inc.
  • PixCell Medical Technologies
  • Polymedco, Inc
  • Precision Biosensor
  • Preventis GmbH
  • Princeton Biomeditech Corporation
  • PTS Diagnostics
  • Qualigen, Inc.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Radiometer Medical A/S
  • Response Biomedical Corp.
  • Reszon Diagnostics International Sdn. Bhd.
  • Revvity
  • Roche Diagnostic Corporation
  • Savyon Diagnostics Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Syntron Bioresearch, Inc.
  • Sysmex Corporation
  • TECHLAB, Inc.
  • Teco Diagnostics
  • Thermo Fisher Scientific, Inc
  • Tosoh Bioscience, Inc.
  • Trinity Biotech PLC
  • True Diagnostics
  • VedaLab
  • Vircell
  • WAMA Diagnostica
  • Werfen Group
  • Zeus Scientific, Inc
目次
Product Code: 25-071KA

Kalorama Information's new report, "Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025", provides an in-depth analysis of one of the most pivotal segments of the in vitro diagnostics (IVD) industry with market estimates and forecasts spanning 2024-2029. Immunoassays-diagnostic tests that detect target analytes via antibody-antigen interactions-are foundational tools in clinical laboratories and point-of-care (POC) settings, enabling the detection of proteins, hormones, drugs, and infectious agents.

The global immunoassay market continues to expand, driven by advances in automation, miniaturization, multiplexing, and biomarker discovery. Despite being a mature technology, immunoassays are evolving rapidly to meet modern healthcare needs-from central labs to self-testing applications.

Market Segmentation

By Setting

  • Centralized Lab-Based Immunoassays:
    • Used in core labs for diagnostics, monitoring, and screening.
    • Market Sales: Major contributors include infectious diseases, cardiac markers, and tumor markers.
    • Top segments covered:
      • Infectious Disease
      • Cardiac Markers
      • Metabolic Disorders & Hormones
      • Tumor Markers
      • Autoimmune & Allergy Testing
  • Point-of-Care (POC) Immunoassays:
    • Includes lateral flow and other rapid tests in hospitals, clinics, retail settings, and self-testing.
    • Rapidly growing due to ease of use and decentralized access.
    • Top segments covered:
      • Infectious Disease
      • Hormone/Fertility
      • Cardiac Markers
      • Oncology & FOBT
      • Toxicology

Breakout By Disease Category

  • Infectious Disease: Largest and most diverse segment; includes tests for HIV, hepatitis, MRSA, STDs, COVID-19, and TORCH.
  • Cardiac Markers: Strong growth from heart failure and acute care testing.
  • Hormones & Fertility: High usage in both labs and POC; includes reproductive and thyroid hormones.
  • Oncology/Tumor Markers: Focus on PSA, CEA, CA-125, AFP with lab-based dominance.
  • Toxicology & Drug Monitoring: Used in pain management, emergency medicine, and substance abuse programs.
  • Autoimmune & Allergy: Emerging targets and expanded panels for systemic diseases.
  • Genetic Testing: Includes prenatal screening and gene expression profiling via immunoassay platforms.
  • Other Emerging Areas: Alzheimer's disease, gastrointestinal disorders, transplant medicine, and women's health (e.g., preeclampsia).

Analysis of Geographic Trends

  • Developed Markets:
    • North America and Western Europe dominate due to high healthcare infrastructure and adoption of advanced diagnostics.
    • Developed Asia Pacific also plays a key role.
  • Emerging Markets:
    • Immunoassays are key to expanding access in Latin America, Eastern Europe, Southeast Asia, and Africa, where centralized diagnostics are limited.
    • Lateral flow and self-testing are critical tools in resource-limited settings.

Scope and Methodology

This report presents the global immunoassay market in U.S. dollars, covering the years 2024 through 2029. It analyzes a wide range of immunoassay technologies, from high-throughput lab instruments to manual point-of-care (POC) tests, including rapid immunochromatographic or lateral flow formats.

The primary focus is on developed regions-North America, Western Europe, and developed Asia-Pacific-while also recognizing the importance of POC testing in expanding diagnostic access in underserved areas.

Market data reflects manufacturer revenue rather than retail prices or reimbursements. Segment values generally align with test volumes, as instrument costs are often bundled into per-test pricing.

A blend of primary and secondary research underpins the report's findings. Secondary sources included public and proprietary databases, industry reports, regulatory filings, company publications, and peer-reviewed journals. These sources provided context, competitor identification, and strategic insights.

To validate and deepen the research, Kalorama conducted over 30 interviews with industry experts such as executives, product and marketing leaders, consultants, healthcare professionals, and government representatives. These interviews provided qualitative insights into market dynamics and trends.

Additional outreach to companies yielded specific figures on revenue, market share, and product performance. All data were verified against multiple sources and, when possible, triangulated using public disclosures, proprietary insights, and expert feedback.

Market sizing and forecasts are based on 2024 as the base year, with projections through 2029 supported by historical trends, demographic shifts, technological advances, and global market expansion. Competitive analysis reflects the landscape in 2024, with forward-looking trends identified for subsequent years.

Table of Contents

Chapter 1: Executive Summary

  • Overview
  • Scope and Methodology
  • Market Overview
    • Table 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
    • Figure 1-1: Global Immunoassay Market, 2024-2029 ($ million) [Lab-based, POC-based]
    • Figure 1-2: Global Immunoassay Market Share, 2024-2029 ($ million) [Lab-based, POC-based]
  • Competitive Summary

Chapter 2: Introduction

  • History and Future of Immunoassays
  • Immunoassay Technology Continues to Evolve

Chapter 3: Technology, Trends, and Innovations

  • Overview - Immunoassays
    • Table 3-1: Immunoassay Sensitivity, by Technology Type and Setting (Lab, POC) [CLIA, ELISA, FIA, IHC, LFIA, RIA]
    • Chemiluminescent Immunoassay (CLIA)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Fluoroimmunoassay (FIA)
    • Immunohistochemistry (IHC)
    • Lateral Flow Immunoassay (LFIA)
    • Radioimmunoassay (RIA)
    • Western Blotting
  • Immunoassay Technology Innovations and Emerging Trends
  • Overview - Instrument Platforms
    • Microtiter Plate-Based Immunoassays and Automation
    • Automation in Immunoassays
    • Platform Innovations: Miniaturization, Microfluidics, and Multiplexing
    • Point-of-Care (POC) and Miniaturized Devices
    • Lab-on-a-Chip (LOC) and Biochips
    • Case Example: Veravas VeraBIND Technology
      • Table 3-2: Selected Immunoassay Technologies
  • Specimen Types
    • Blood
    • Urine
    • Saliva
      • Table 3-3: Selected Companies with Saliva or Oral-Fluid Collection Devices

Chapter 4: Market Segment by Setting

  • Centralized Laboratories
    • Table 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
    • Figure 4-1: Global Lab-based Immunoassay Market, by Application Segment, 2024 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
    • Figure 4-2: Global Lab-based Immunoassay Market Distribution, by Application Segment, 2024 (%) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Others]
    • Companies Marketing to Centralized Laboratories
      • Table 4-2: Selected Companies Marketing Central Lab-Based Immunoassays Worldwide
  • Rapid and Point-of-Care Testing
    • Table 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
    • Figure 4-3: Global POC-based Immunoassay Market, by Application Segment, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
    • Figure 4-4: Global POC-based Immunoassay Market Distribution, by Application, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology, Toxicology, Other]
    • POC Testing in Hospitals
    • Physician's Office Laboratories and Clinics
    • Retail Clinics
    • Other Professional POC Testing
    • Self-Testing
    • Companies Marketing Immunoassay for POC Testing
      • Table 4-4: Selected Companies Marketing Immunoassay and/or Lateral Flow Tests for POC Worldwide

Chapter 5: Immunoassay Diagnostic Market Activity by Application

  • Table 5-1: Immunoassay Market Disease Categories
  • Allergy
    • Figure 5-1: Global Allergy Immunoassay Market, 2024-2029 ($ million)
    • Table 5-2: Selected Companies Marketing Immunoassays for Allergy Diagnostics
  • Autoimmune Disease
    • Figure 5-2: Global Autoimmune Disease Immunoassay Market, 2024-2029 ($ million)
    • Table 5-3: Selected Autoantibodies Detected by Autoimmune Immunoassays
  • Cardiac Markers
    • Figure 5-3: Global Cardiac Marker Immunoassay Market, 2024-2029 ($ million)
    • Table 5-4: Selected Cardiac Marker Immunoassays
    • Table 5-5: Selected Cardiac Marker Innovations
  • Genetic Testing
    • Figure 5-4: Global Genetic Immunoassay Market, 2024-2029 ($ million)
  • Infectious Disease
    • Figure 5-5: Global Infectious Disease Immunoassay Market, 2024-2029 ($ million)
  • Lab-based Infectious Disease Immunoassays
    • Table 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
    • Figure 5-6: Global Lab-based Infectious Disease Immunoassay Sales, 2024 ($ million) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
    • Figure 5-7: Global Lab-based Infectious Disease Immunoassay Market Share, 2024 (%) [Blood banking, C. diff, Hepatitis, HIV, MRSA, Respiratory, STD, Staphylococci, TORCH, Other infectious diseases]
    • Blood Screening
      • Table 5-7: Selected Infectious Disease Immunoassays
      • Table 5-8: Selected Companies Marketing Immunoassays for Infectious Disease
    • Hepatitis
    • Lyme Disease
    • Rapid and POC Testing
    • Retroviral
    • Sexually Transmitted Diseases
    • ToRCH
    • COVID-19
      • Table 5-9: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2
    • Other Infectious Diseases
  • Metabolic Disorders and Other Hormones
    • Figure 5-8: Global Metabolic and Hormone Disorder Immunoassay Market, 2024-2029 ($ million)
    • Table 5-10: Selected Metabolic and Other Hormone Immunoassays
    • Fertility/Pregnancy/Reproductive Hormones
      • Table 5-11: Selected Fertility and Reproductive Hormone Immunoassays
    • Thyroid
      • Table 5-12: Selected Thyroid Hormone Immunoassays
  • Oncology - Tumor Markers
    • Figure 5-9: Global Oncology Immunoassay Market, 2024-2029 ($ million)
    • Lab-based Oncology Immunoassays
      • Table 5-13: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
      • Figure 5-10: Global Lab-based Tumor Marker Immunoassay Sales, 2024 ($ million) [AFP, CA-125, CEA, PSA, Others]
      • Figure 5-11: Global Lab-based Tumor Marker Immunoassay Market Share, 2024 (%) [AFP, CA-125, CEA, PSA, Others]
      • Table 5-14: Selected Companies Marketing Immunoassays for Tumor Markers
      • Table 5-15: Selected Companies Marketing Metabolic Immunoassays
  • Toxicology
    • Figure 5-12: Global Toxicology Marker Immunoassay Market, 2024-2029 ($ million)
    • Drugs of Abuse
      • Table 5-16: Selected Drugs of Abuse Immunoassays
    • Therapeutic Drug Monitoring
      • Table 5-17: Selected Therapeutic Drug Monitoring Immunoassays
  • Other Disease Categories in Immunoassay Disease Market
    • Figure 5-13: Other Immunoassay Market, 2024-2029 ($ million)
    • Table 5-18: Selected Other Immunoassays

Chapter 6: Market Opportunities and Issues for Immunoassays

  • Immunoassay Market - Overview
  • Immunoassay Market Drivers and Challenges
    • Drivers
  • New and Emerging Areas of Immunoassay Innovation
    • Gastrointestinal Disorders
      • Table 6-1: Selected Inflammatory Bowel Disease Test Innovations
    • Transplant Management
      • Table 6-2: Selected Immunoassays for Transplant Medicine
    • Preeclampsia
      • Table 6-3: Selected Women's Health Innovations
    • Alzheimer's Disease
      • Table 6-4: Selected Innovations for Alzheimer's Disease Immunoassays
      • Table 6-5: Selected Immunoassay Innovations
  • Emerging International Markets
    • Table 6-6: Selected Companies Outside of North America, Europe, or Japan Marketing Immunoassays
  • Lab-Developed Tests
  • Staffing Shortages
  • Outlook for Immunoassays

Chapter 7: Immunoassay Market Analysis

  • Market Overview and Market Segments
    • Table 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
    • Figure 7-1: Global Immunoassay Market, by Laboratory Setting, 2024-2029 ($ million) [Lab-based, POC-based]
    • Figure 7-2: Global Immunoassay Market Segment Share, by Laboratory Setting, 2024 (%) [Lab-based, POC-based]
    • Central Lab-based Immunoassay Market
      • Table 7-2: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
      • Figure 7-3: Global Lab-based Immunoassay Market, by Application, 2024-2029 ($ million) [Allergy, Autoimmune, Cardiac Markers, Genetic, Infectious Disease, Metabolic Disorders and Other Hormones, Toxicology, Tumor Markers, Other]
    • Point of Care/Rapid Test Immunoassays by Disease Category
      • Table 7-3: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
      • Figure 7-4: Global POC Immunoassay Market Analysis, by Disease Category, 2024 ($ million) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
      • Figure 7-5 Global POC Immunoassay Market Analysis, by Disease Category Market Share, 2024 (%) [Cardiac Markers, Hormone/Fertility, Infectious Disease, Oncology (markers and FOBT), Toxicology, Other]
    • Immunoassay Market by Technology Type
      • Table 7-4: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
      • Figure 7-6: Global Immunoassay Market, by Technology Segment, 2024-2029 ($ million) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
      • Table 7-5: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
      • Figure 7-7: Global Immunoassay Market Share, by Technology Segment, 2024 (%) [CLIA, ELISA, FIA, IHC, LFIA, RIA, Other]
  • Competitive Analysis
    • Table 7-6: Global Immunoassay Market Analysis, by Competitor Revenues ($ million) and Market Share (%), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMerieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
    • Figure 7-8: Global Immunoassay Market Analysis, by Competitor Revenues ($ million), 2024 [Abbott, Becton Dickinson, Bio-Rad, bioMerieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
    • Figure 7-9: Global Immunoassay Market Analysis, by Competitor Market Share, 2024 (%) [Abbott, Becton Dickinson, Bio-Rad, bioMerieux, Bruker - CALID, Danaher, DiaSorin, QuidelOrtho, Revvity, Roche, Siemens Healthineers, Thermo Fisher Scientific, Others]
  • Immunoassay Market by Geographic Regions
    • Table 7-7: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
    • Figure 7-10: Immunoassay Market, by Geographic Region, 2024-2029 ($ million) [Asia Pacific, Europe, North America, Rest of World]
    • Figure 7-11: Immunoassay Market Share, by Geographic Region, 2024 (%) [Asia Pacific, Europe, North America, Rest of World]
    • North America
    • Europe
      • Table 7-8: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
      • Figure 7-12: Immunoassay Market, by European Geographic Region, 2024 ($ million) [France, Germany, Italy, Spain, United Kingdom, Others]
      • Figure 7-13: Immunoassay Market Share, by European Geographic Region, 2024 (%) [France, Germany, Italy, Spain, United Kingdom, Others]
    • Asia Pacific
      • Table 7-9: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
      • Figure 7-14: Immunoassay Market, by Asia Pacific Geographic Region, 2024 ($ million) [China, India, Japan, Others]
      • Figure 7-15: Immunoassay Market Share, by Asia Pacific Geographic Region, 2024 (%) [China, India, Japan, Others]
    • Rest of World
      • Table 7-10: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
      • Figure 7-16: Immunoassay Market, by Rest of World Geographic Region, 2024 ($ million) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]
      • Figure 7-17: Immunoassay Market Share, by Rest of World Geographic Region, 2024 (%) [Brazil, Mexico, Saudi Arabia, South Africa, Turkey, Others]

Chapter 8: Company Profiles

  • 1 Step Detect Associates, LLC
    • Table 8-1: 1-Step Detect Associates Corporate Summary
    • Company Overview
    • Products
  • Abbott Laboratories
    • Table 8-2: Abbott Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-3: Abbott Revenues, 2023-2024 ($millions)
  • Abingdon Health, Ltd.
    • Table 8-4: Abingdon Health Corporate Summary
    • Company Overview
    • Products
  • Access Bio, Inc.
    • Table 8-5: Access Bio Summary
    • Company Overview
    • Products
  • AccuBioTech Co, Ltd.
    • Table 8-6: AccuBioTech Corporate Summary
    • Company Overview
    • Products
  • ACON Laboratories, Inc
    • Table 8-7: ACON Laboratories Corporate Summary
    • Company Overview
    • Products
  • AESKU. DIAGNOSTICS
    • Table 8-8: AESKU.DIAGNOSTICS Corporate Summary
    • Company Overview
    • Products
  • Aidian Oy
    • Table 8-9: Aidian Corporate Summary
    • Company Overview
    • Products
  • Alfa Scientific Designs, Inc
    • Table 8-10: Alfa Scientific Design
    • Company Overview
    • Products
  • American Laboratory Products Company (ALPCO)
    • Table 8-11: American Laboratory Products Corporate Summary
    • Company Overview
    • Products
  • Anbio Biotechnology
    • Table 8-12: Anbio Biotechnology Corporate Summary
    • Company Overview
    • Products
  • ARKRAY, Inc
    • Table 8-13: ARKRAY Corporate Summary
    • Company Overview
    • Products
  • Arlington Scientific, Inc.
    • Table 8-14: Arlington Scientific Corporate Summary
    • Company Overview
    • Products
  • Artron Laboratories Inc.
    • Table 8-15: Artron Laboratories Corporate Summary
    • Company Overview
    • Products
  • Associates of Cape Cod, Inc. (ACC)
    • Table 8-16: Associates of Cape Cod Corporate Summary
    • Company Overview
    • Products
  • Autobio Diagnostics Co., Ltd
    • Table 8-17: Autobio Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Avioq, Inc.
    • Table 8-18: Avioq Corporate Summary
    • Company Overview
    • Products
  • Awareness Technology
    • Table 8-19: Awareness Technology Corporate Summary
    • Company Overview
    • Products
  • Beckman Coulter, Inc
    • Table 8-20: Beckman Coulter Corporate Summary
    • Company Overview
    • Products
  • Becton Dickinson (BD)
    • Table 8-21: BD Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-22: BD Corporation Revenue, 2023-2024 ($ million)
  • Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
    • Table 8-23: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
    • Company Overview
    • Products
  • Bhat Bio-Tech India Private Ltd. (BBI)
    • Table 8-24: Bhat Bio-Tech India Private Corporate Summary
    • Company Overview
    • Products
  • BioCheck, Inc.
    • Table 8-25: BioCheck Corporate Summary
    • Company Overview
    • Products
  • Biohit Oyj (Biohit Healthcare)
    • Table 8-26: Biohit Oyj Corporate Summary
    • Company Overview
    • Products
  • bioLytical Laboratories
    • Table 8-27: bioLytical Laboratories Corporate Summary
    • Company Overview
    • Products
  • BioMedomics, Inc.
    • Table 8-28: BioMedomics Corporate Summary
    • Company Overview
    • Products
  • Biomerica
    • Table 8-29: Biomerica Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-30: Biomerica Corporation Revenue, 2023-2024 ($ million)
  • bioMerieux SA
    • Table 8-31: bioMerieux SA Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-32: bioMerieux Revenues, 2023-2024 (Euro- millions)
  • BioPorto Diagnostics
    • Table 8-33: BioPorto Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-34: BioPorto Diagnostics Revenues, 2023-2024 (DKK millions)
  • Bio-Rad Laboratories Inc.
    • Table 8-35: Bio-Rad Labs Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-36: Bio-Rad Corporation Revenue, 2023-2024 ($ million)
  • Bioscience (Tianjin) Diagnostic Technology Co., Ltd.
    • Table 8-37: Bioscience (Tianjin) Diagnostic Technology Corporate Summary
    • Company Overview
    • Products
  • Bio-Techne
    • Table 8-38: Bio-Techne Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-39: Bio-Techne, 2023-2024 ($ million)
  • Biotron Diagnostics, Inc.
    • Table 8-40: Biotron Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Boditech Med Inc.
    • Table 8-41: Boditech Med Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-42: Boditech Med Revenues 2023-2024 (KRW billion)
  • Boson Biotech Co. Ltd
    • Table 8-43: Boson Biotech Corporate Summary
    • Company Overview
    • Products
  • BUHLMANN Laboratories AG
    • Table 8-44: BUHLMANN Laboratories Summary
    • Company Overview
    • Products
  • Certest Biotec
    • Table 8-45: Certest Biotec Summary
    • Company Overview
    • Products
  • Chembio Diagnostic Systems, Inc.
    • Table 8-46: Chembio Diagnostic Corporate Summary
    • Company Overview
    • Products
  • Clarity Diagnostics, LLC
    • Table 8-47: Clarity Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Confirm Biosciences
    • Table 8-48: Confirm Biosciences Corporate Summary
    • Company Overview
    • Products
  • CTK Biotech, Inc.
    • Table 8-49: CTK Biotech Corporate Summary
    • Company Overview
    • Products
  • Diagenics Group SE
    • Table 8-50: Diagenics Group Corporate Summary
    • Company Overview
    • Products
  • DIALAB GmbH
    • Table 8-51: DIALAB Summary
    • Company Overview
    • Products
  • Diametra
    • Table 8-52: Diametra Corporate Summary
    • Company Overview
    • Products
  • DiaSorin S.p.A.
    • Table 8-53: DiaSorin Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-54: DiaSorin 2023-2024 (Euro- thousand)
  • DiaSource ImmunoAssays SA
    • Table 8-55: DiaSource ImmunoAssays Corporate Summary
    • Company Overview
    • Products
  • DiaSys Diagnostic Systems GmbH (Mindray)
    • Table 8-56: DiaSys Diagnostic Systems Corporate Summary
    • Company Overview
    • Products
  • Diazyme Laboratories, Inc.
    • Table 8-57: Diazyme Laboratories Corporate Summary
    • Company Overview
    • Products
  • Dr. Fooke-Achterrath Laboratorien GmbH
    • Table 8-58: Dr. Fooke-Achterrath Laboratorien Corporate Summary
    • Company Overview
    • Products
  • Eiken Chemical Co Ltd.
    • Table 8-59: Eiken Chemical Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-60: Eiken Chemical Revenues, 2023-2024 (million yen)
  • EKF Diagnostics Holdings plc
    • Table 8-61: EKF Diagnostics Corporate Summary
    • Company Overview
    • Products
  • ELITechGroup S.A.S.
    • Table 8-62: ELITechGroup Corporate Summary
    • Company Overview
    • Products
  • Eurobio Scientific
    • Table 8-63: Eurobio Scientific Corporate Summary
    • Company Overview
    • Products
  • Eurospital Spa
    • Table 8-64: Eurospital Summary
    • Company Overview
    • Products
  • EY Laboratories
    • Table 8-65: EY Laboratories Summary
    • Company Overview
    • Products
  • Fujirebio-US, Inc.
    • Table 8-66: Fujirebio Corporate Summary
    • Company Overview
    • Products
  • GenBio
    • Table 8-67: GenBio Corporate Summary
    • Company Overview
    • Products
  • Gold Standard Diagnostics
    • Table 8-68: Gold Standard Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Grifols International S.A.
    • Table 8-69: Grifols International S.A. Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-70: Grifols Revenue, 2023-2024 (Euro- million)
  • Hemosure, Inc.
    • Table 8-71: Hemosure Corporate Summary
    • Company Overview
    • Products
  • HYCOR Biomedical, Inc.
    • Table 8-72: HYCOR Biomedical Corporate Summary
    • Company Overview
    • Products
  • Immuno-Mycologics, Inc.
    • Table 8-73: Immuno-Mycologics Corporate Summary
    • Company Overview
    • Products
  • Immunosciences Lab, Inc.
    • Table 8-74: Immunosciences Lab Corporate Summary
    • Company Overview
    • Products
  • Immunostics, Inc
    • Table 8-75: Immunostics Corporate Summary
    • Company Overview
    • Products
  • InBios International, Inc.
    • Table 8-76: InBios Corporate Summary
    • Company Overview
    • Products
  • JAL Innovation PTE LTD
    • Table 8-77: JAL Innovation Corporate Summary
    • Company Overview
    • Products
  • Jant Pharmacal Corporation
    • Table 8-78: Jant Pharmacal Summary
    • Company Overview
    • Products
  • J Mitra & Co., Pvt. Ltd.
    • Table 8-79: J Mitra Corporate Summary
    • Company Overview
    • Products
  • KRONUS
    • Table 8-80: KRONUS Corporate Summary
    • Company Overview
    • Products
  • Kypha
    • Table 8-81: Kypha Corporate Summary
    • Company Overview
    • Products
  • Labsystems Diagnostics Oy
    • Table 8-82: Labsystems Diagnostics Corporate Summary
    • Company Overview
    • Products
  • LamdaGen Corporation
    • Table 8-83: LamdaGen Corporate Summary
    • Company Overview
    • Products
  • LifeSign, LLC
    • Table 8-84: LifeSign Summary
    • Company Overview
    • Products
  • Macherey-Nagel GmbH & Co. KG
    • Table 8-85: Macherey-Nagel Corporate Summary
    • Company Overview
    • Products
  • Medix Biochemica
    • Table 8-86: Medix Biochemica Summary
    • Company Overview
    • Products
  • MedMira, Inc
    • Table 8-87: MedMira Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-88: MedMira, Revenues 2023-2024 ($ thousands)
  • Mercodia AB
    • Table 8-89: Mercodia AB Summary
    • Company Overview
    • Products
  • Meridian BioScience, Inc
    • Table 8-90: Meridian BioScience Corporate Summary
    • Company Overview
    • Products
  • Monobind, Inc
    • Table 8-91: Monobind Corporate Summary
    • Company Overview
    • Products
  • Nano-Ditech Corporation
    • Table 8-92: Nano-Ditech Corporate Summary
    • Company Overview
    • Products
  • Nexus Dx Inc
    • Table 8-93: Nexus Dx Corporate Summary
    • Company Overview
    • Products
  • Nova Biomedical, Corp.
    • Table 8-94: Nova Biomedical Corporate Summary
    • Company Overview
    • Products
  • Oasis Diagnostics Corporation
    • Table 8-95: Oasis Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Operon
    • Table 8-96: Operon Corporate Summary
    • Company Overview
    • Products
  • OPKO Health, Inc
    • Table 8-97: OPKO Health Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-98: OPKO Health Revenues, 2023-2024 ($ million)
  • OraSure Technologies, Inc.
    • Table 8-99: OraSure Technologies Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-100: OraSure Revenues, 2023-2024 ($ million)
  • PixCell Medical Technologies
    • Table 8-101: PixCell Corporate Summary
    • Company Overview
    • Products
  • Polymedco, Inc
    • Table 8-102: Polymedco Corporate Summary
    • Company Overview
    • Products
  • Precision Biosensor
    • Table 8-103: Precision Biosensor Corporate Summary
    • Company Overview
    • Products
  • Preventis GmbH
    • Table 8-104: Preventis Corporate Summary
    • Company Overview
    • Products
  • Princeton Biomeditech Corporation
    • Table 8-105: Princeton Biomeditech Corporate Summary
    • Company Overview
    • Products
  • PTS Diagnostics
    • Table 8-106: PTS Corporate Summary
    • Company Overview
    • Products
  • Qualigen, Inc.
    • Table 8-107: Qualigen Corporate Summary
    • Company Overview
    • Products
  • Quanterix Corporation
    • Table 8-108: Quanterix Corporate Summary
    • Company Overview
    • Products
  • QuidelOrtho Corporation
    • Table 8-109: QuidelOrtho Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-110: QuidelOrtho Revenues, 2023-2024 ($ million)
  • Radiometer Medical A/S
    • Table 8-111: Radiometer Medical Corporate Summary
    • Company Overview
    • Products
  • Response Biomedical Corp.
    • Table 8-112: Response Biomedical Corporate Summary
    • Company Overview
    • Products
  • Reszon Diagnostics International Sdn. Bhd.
    • Table 8-113: Reszon Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Revvity
    • Table 8-114: Revvity Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-115: Revvity Revenues, 2023-2024 ($ million)
  • Roche Diagnostic Corporation
    • Table 8-116: Roche Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-117: Roche Diagnostics Revenue, 2023-2024 (CHF millions)
  • Savyon Diagnostics Ltd.
    • Table 8-118: Savyon Diagnostics Summary
    • Company Overview
    • Products
  • Sekisui Diagnostics LLC
    • Table 8-119: Sekisui Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Siemens Healthineers
    • Table 8-120: Siemens Healthineers Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-121: Siemens Healthineers Revenue, 2023-2024 (Euro- millions)
  • Syntron Bioresearch, Inc.
    • Table 8-122: Syntron Bioresearch Corporate Summary
    • Company Overview
    • Products
  • Sysmex Corporation
    • Table 8-123: Sysmex Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table 8-124: Sysmex Revenues, 2023-2024 (billion yen)
  • TECHLAB, Inc.
    • Table 8-125: TECHLAB Corporate Summary
    • Company Overview
    • Products
  • Teco Diagnostics
    • Table 8-126: Teco Diagnostics Corporate Summary
    • Company Overview
    • Products
  • Thermo Fisher Scientific, Inc
    • Table 8-127: Thermo Fisher Scientific Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-128: Thermo Fisher Scientific Revenues, 2023-2024 ($ million)
  • Tosoh Bioscience, Inc.
    • Table 8-129: Tosoh Bioscience Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table 8-130: Tosoh Corporation Revenue, 2023-2024 (billion yen)
  • Trinity Biotech PLC
    • Table 8-131: Trinity Biotech Corporate Summary
    • Company Overview
    • Products
  • True Diagnostics
    • Table 8-132: True Diagnostics Corporate Summary
    • Company Overview
    • Products
  • VedaLab
    • Table 8-133: VedaLab Corporate Summary
    • Company Overview
    • Products
  • Vircell
    • Table 8-134: Vircell Corporate Summary
    • Company Overview
    • Products
  • WAMA Diagnostica
    • Table 8-135: WAMA Diagnostica Corporate Summary
    • Company Overview
    • Products
  • Werfen Group
    • Table 8-136: Werfen Group Corporate Summary
    • Company Overview
    • Products
  • Zeus Scientific, Inc.
    • Table 8-137: Zeus Scientific Corporate Summary
    • Company Overview
    • Products